Zhengyu Cao

28PUBLICATIONS
59CO-AUTHORS
Water treatment processesSensory systemsCancer therapy (excl. chemotherapy and radiation therapy)Transition metal chemistryPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 14, 2026
Orally available Colivin traps TRPV3 in an inactive state and suppresses intestinal inflammation.

|Feb 10, 2026
Molecular determinant of low-voltage dependence of human Nav1.7 inactivation revealed by efficacy-based Nav1.7 selective inhibitor.

Fang Zhao, Chuchu Xi, Jie Li

|Jan 28, 2026
Scutellarein from Erigeron breviscapus Inhibits Apoptosis-Mediated Epithelial Barrier Disruption and Alleviates Cigarette Smoke-Induced Lung Injury.

Chuchu Xi, Hongrong Fu, Xu Qin

|Jan 08, 2026
Noncanonical calcium-independent TRPM4 activation governs intestinal fluid homeostasis.

Yaru Liu, Jinhong Hu, Chu Xue

|Jan 31, 2025
TRPC6 suppresses liver fibrosis by inhibiting hepatic stellate cell activation via CaMK4-CREB pathway.

Shan Jiang, Yujing Wang, Younan Ren

|Oct 04, 2024
Plumbagin, a novel TRPV2 inhibitor, ameliorates microglia activation and brain injury in a middle cerebral artery occlusion/reperfusion mouse model.

Meihuizi Ding, Rui Han, Yiming Xie

Pageof 5

Frequent Collaborators

6 joint publications

Michael X Zhu

4 joint publications

Chun-Lei Zhang

3 joint publications

C Benjamin Naman

3 joint publications

Isaac N Pessah